Joseph Wesley Quillin, MD
Skull Base Surgeon
Joseph Quillin, MD is a fellowship-trained neurological surgeon specializing in skull base surgery, minimally invasive endoscopic surgery of the pituitary gland, neurosurgical oncology, and stereotactic radiosurgery. He graduated summa cum laude with membership in multiple academic honor societies including Phi Beta Kappa, earning his Bachelor of Science degree in Biology with minor concentrations in Chemistry and Latin at Millsaps College. He attended Louisiana State University Health Sciences Center – Shreveport for medical school, furthering a lifelong interest in neurosurgery and skull base surgery under the tutelage of Dr. Anil Nanda. He graduated from LSU as a member of the Alpha Omega Alpha Honor Medical Society. He matched into neurosurgery residency at Emory University, and he completed his training there in June 2020. He completed a CAST-approved neurosurgical oncology fellowship while at Emory from 2017-2018. With the mentorship of Dr. Nelson Oyesiku and Dr. Jeffrey Olson, he focused his interests on the endoscopic treatment of pituitary tumors, acoustic neuroma surgery, open surgical approaches to skull base tumors, the efficacy of radiosurgery on skull base tumors, and clinical trials exploring novel treatment of brain tumors such as glioblastoma multiforme. Following his graduation from Emory University’s neurosurgery program, Dr. Quillin completed an additional fellowship in skull base surgery at Rutgers New Jersey Medical School with Dr. Anil Nanda and Dr. James Liu. He completed this fellowship training in 2021.
Dr. Quillin is committed to the advancement of skull base surgery through research, publication, and professional society memberships. He is an active member of the North American Skull Base Society and Congress of Neurological Surgeons. He has contributed to numerous publications and participated in research projects exploring the ideal treatment of skull base tumors. He also has experience in drafting and organizing clinical trials regarding novel treatment of glioblastoma. His goal is to provide personalized and individual treatment for each his patients, believing that proper patient selection, thorough patient education, and sound surgical judgement are the bedrock of good surgical outcomes and proper patient care.